A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants

Condition:   Healthy Interventions:   Drug: Dabigatran etexilate (DE);   Drug: Rosuvastatin;   Drug: PF-07081532 Sponsor:   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials